Can anyone suggest why the FDA are being so slow in their response regards the p3 trials. It always appeared that it would be a clear cut decision to give the go ahead and yet here they are taking a long time to make a decision , given PAR has fast track designation.
FDA delay for ph 3 trial approval
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $216.0K | 1.078M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6309 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 63209 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |